Nutrex-Hawaii Introduces Its #1 Selling BioAstin® Hawaiian Astaxanthin® in a Retail-Ready, Sugar-Free, Vegan Gummy Format
The new gummy offers an industry-leading 12mg of Hawaiian Astaxanthin® per serving – 6000 times the antioxidant power of Vitamin C – with science-backed, multifunctional benefits and a 40-year legacy of farm-direct transparency and traceability.
KAILUA KONA, Hawaii, March 28, 2024--(BUSINESS WIRE)--Nutrex-Hawaii, Inc., a wholly owned subsidiary of Cyanotech Corporation, unveils its #1 selling BioAstin® Hawaiian Astaxanthin® dietary supplement in a groundbreaking sugar free gummy format, enriched with an industry-leading 12mg of natural Hawaiian Astaxanthin per daily serving.
At the forefront of natural microalgae innovation, Nutrex-Hawaii addresses the evolving preferences of today's discerning consumers with its new gummies, offering a host of distinct benefits:
Sourced from natural Hawaiian microalgae grown outdoors under natural sun – never synthetic, fermented, nor cultivated in laboratory environments, as much of today’s astaxanthin is sourced,
Backed by scientific research supporting comprehensive, full body health objectives of today’s consumer,
Grown in Hawaii, ensuring unparalleled origin traceability and sustainability.
"Today's consumers seek brands that align with their values of efficacy, transparency, and sustainability. With our demonstrated 40-year legacy of Hawaiian microalgae production and innovation, we're enthusiastic about providing a safe, responsible, and sustainable solution that caters to the growing global interest in gummies with multi-functional benefits," stated Collette Kakuk, Chief Strategic and Commercial Officer. "Our new BioAstin® Hawaiian Astaxanthin® gummies offer consumers a convenient way to experience the benefits of our number 1 selling brand, in an easy to consume and tasty gummy format."
BioAstin®, derived from natural Hawaiian Astaxanthin®, is a powerful natural antioxidant extracted from Haematococcus pluvialis algae, renowned for its tangible health benefits for diverse health goals, including not only healthy agers, but also active lifestyle and beauty from within audiences. The benefits of BioAstin® Hawaiian Astaxanthin® are supported by longstanding, robust clinical science, encompassing eye, skin, joint, and heart health, as well as healthy inflammatory response and post-exercise recovery☨.
"With antioxidant potency 6000 times greater than Vitamin C, our BioAstin® Hawaiian Astaxanthin® gummies provide consumers with powerful benefits for full body wellness. Our 12mg formulation sets our gummies apart from others in the market, including exciting skin health claims important to consumers today, such as improving moisture retention and hydration☨, reducing appearance of wrinkles☨, and also skin health during UV and sun exposure☨," added Kakuk.
The gummies are further enhanced with 25mcg (1000 IU) of vitamin D3, and are sugar free, sweetened with monk fruit and stevia, non-GMO, gluten-free, and vegan.
The new gummies were soft launched at the recent Natural Products Expo West and are currently being nationally rolled out in mass and specialty retail channels and are also available on Amazon.com and https://www.nutrex-hawaii.com.
For more information about Nutrex-Hawaii and BioAstin® Hawaiian Astaxanthin® gummies, please visit https://www.nutrex-hawaii.com.
About Nutrex-Hawaii, Inc.: Nutrex-Hawaii, a wholly owned subsidiary of Cyanotech Corporation, is the global leader in natural, premium microalgae dietary supplements for health and wellness, leading the natural channel category with its BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica® brands. All Nutrex-Hawaii microalgae products are naturally and sustainably produced on a purpose-built 96-acre facility in Kona, Hawaii. Distributed through premium retail locations in the United States, including Whole Foods, Sprouts, Costco, and online at Amazon.com and https://www.nutrex-hawaii.com, Nutrex-Hawaii products are trusted by consumers worldwide.
☨These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnosis, treat, cure or prevent any disease.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240328602781/en/
Contacts
Felicia Ladin
(808) 334-9455
investorrelations@cyanotech.com
